The original success of Sildenafil undeniably transformed the medication landscape, but investing in companies heavily reliant on unbranded versions presents a uncertain picture. Although early returns were significant, the expiration of patents and the rise of discounted alternatives have eroded the customer base. Therefore, a thorough evaluation